¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Syndrome, phantom limb"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
  • tarsal tunnel syndrome
    ¹ß¸ñ±¼ÁõÈıº, Á·±Ù°üÁõÈıº
  • ulnar tunnel syndrome
    ÀÚ±¼ÁõÈıº, ô°ñ°üÁõÈıº
  • uncombable hair syndrome
    ¾ûÅ´ÅÐÁõÈıº
  • velocardiofacial syndrome
    ÀÔõÀå½ÉÀå¾ó±¼ÁõÈıº, ±¸°³½ÉÀå¾È¸éÁõÈıº
  • vanishing lung syndrome
    ¼Ò¸êÆóÁõÈıº, »ç¶óÁö´ÂÇãÆÄÁõÈıº
  • vanishing testes syndrome
    ¼Ò¸ê°íȯÁõÈıº
  • Wiskott-Aldrich syndrome
    ºñ½ºÄÚÆ®-¿Ãµå¸®Ä¡ÁõÈıº
  • withdrawal syndrome
    ±Ý´ÜÁõÈıº
  • Wolff-Parkinson-White syndrome
    ¿ùÇÁ-ÆÄŲ½¼-È­ÀÌÆ®ÁõÈıº
  • wasting syndrome
    ¼Ò¸ðÁõÈıº
  • Waterhouse-Friderichsen syndrome
    ¿öÅÍÇϿ콺-ÇÁ¸®µ¥¸¯¼¾ÁõÈıº
  • Werner¡¯s syndrome
    º£¸£³ÊÁõÈıº
  • Wernicke¡¯s syndrome
    º£¸£´ÏÄÉÁõÈıº
  • X-linked lymphoproliferative syndrome
    X¿¬°ü¸²ÇÁ±¸Áõ½ÄÁõÈıº
  • Zollinger-Ellison syndrome
    Á¹¸µ°Å-¿¤¸®½¼ÁõÈıº
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
  • absent testes syndrome
    °íȯ°á¿©ÁõÈıº
  • abstinence syndrome
    ±Ý´ÜÁõÈıº(Ð×Ó¨ñøý¦ÏØ).
  • acid aspiration syndrome
    À§»ê ÈíÀÔ ÁõÈıº
  • acquired immune deficiency syndrome
    ÈÄõ¼º ¸é¿ª°áÇÌ ÁõÈıº
  • acquired immune deficiency syndrome
    ÈÄõ¼º ¸é¿ª°áÇÌÁõÈıº(ý­ô¸àõ Øóæ¹ÌÀù¹ñøý¦ÏØ)
  • acquired immunodeficiency syndrome
    ÈÄõ¼º¸é¿ª°áÇÌÁõ
  • acquired immunodeficiency syndrome
    ÈÄõ¼º ¸é¿ª°áÇÌ ÁõÈıº
  • acquired immunodeficiency syndrome (AIDS)
    ÈÄõ¼º¸é¿ª°áÇÌÁõ(Èıº)
  • acquired immunodeficiency syndrome(AIDS)
    ÈÄõ¼º ¸é¿ª°áÇÌ ÁõÈıº
  • acute brain syndrome
    ±Þ¼º ³úÁõÈıº(¡­Òàñøý¦ÏØ).
  • acute fulminating meningococcemia ; Waterhouse Friderichsen syndrome
    ±Þ¼º Àü°Ý¼º ¼ö¸·±¸±Õ±ÕÇ÷Áõ.
  • acute radiation syndrome
    ±Þ¼º¹æ»ç¼±ÁõÈıº
  • acute radiation syndrome
    ±Þ¼º¹æ»ç¼±ÁõÈıº(¡­Û¯ÞÒàÊñøý¦ÏØ)
  • adherence syndrome, Johnson
    ÁÔ½¼À¯ÂøÁõÈıº
  • adhesive syndrome
    À¯ÂøÁõÈıº
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
  • chronic organic brain syndrome
    ¸¸¼º ±âÁú¼º ³úÁõÈıº
  • chronic social breakdown syndrome
    ¸¸¼º »çȸ¼º ºØ±«ÁõÈıº
  • churg-strauss syndrome
    ó¸£±× ½ºÆ®¶ó¿ì½º ÁõÈıº(¡­ñøý¦ÏØ)
  • cleft palate lateral synechia syndrome
    ±¸°³¿­ ÃøÀ¯Âø ÁõÈıº
  • cleft palate syndrome
    ÀÔõÀå°¥¸²ÁõÈıº
  • clinical syndrome
    ÀÓ»ó(Àû) ÁõÈıº
  • clumsy child syndrome
    µÐÇÑ ¾Æµ¿ÁõÈıº(ä®ÔÛñøý¦ÏØ)
  • clumsy hand syndrome
    ¼­Å÷¼Õ ÁõÈıº(¡­ñøý¦ÏØ).
  • clumsy-hand-dysarthric syndrome
    µÐ¼ö±¸À½Àå¾Ö ÁõÈıº
  • co-contraction syndrome
    µ¿½Ã¼öÃàÁõÈıº
  • cold agglutinin syndrome
    ÇÑ·© ÀÀÁý¼Ò ÁõÈıº
  • cold agglutinin syndrome
    ÇÑ·©ÀÀÁý¼ÒÁõÈıº
  • cold hemolysin syndrome
    ÇÑ·© ¿ëÇ÷¼Ò ÁõÈıº
  • combined immunity deficiency syndrome
    º¹Çո鿪°áÇÌÁõÈıº.
  • combined immunodeficiency syndrome
    º¹ÇÕÇü ¸é¿ª°áÇÌ ÁõÈıº
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 19
SAS sarcoma amplified sequence; self-rating anxiety scale; short arm splint; Sklar Aphasia Scale; sleep ...
SDS same day surgery; school dental services; self-rating depression scale; sensory deprivation syndrome...
SJS Stevens-Johnson syndrome; stiff joint syndrome; Swyer-James syndrome
SL sarcolemma; sclerosing leukoencephalopathy; secondary leukemia; segment length; sensation level; sen...
AIS Androgen Insensitive Syndrome
  = Testicular Feminization Syndrome
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 19
DHF/DSS Dengue Haemorrhagic Fever/Dengue Shock Syndrome
DSS Dengue Shock Syndrome
DDS Denys Drash syndrome
DGS Di George syndrome
DILS Diffuse Infiltrative Lymphocytosis Syndrome
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • Mallory-Weiss syndrome
    ¸»·Î¸®-¹ÙÀ̽º ÁõÈıº, ¸È·Î¸®¿ÍÀ̽º ÁõÈıº
    1. ±¸Åä¿¡ ÀÇÇØ ½ÄµµÀ§ °áÇÕºÎÀÇ Á¡¸· ¿­»óÀ» ¸»Çϴµ¥, ¹ß»ý ±âÀüÀ¸·Î´Â ½ÉÇÑ ±¸Åä ½Ã °©ÀÛ½º·± º¹¾ÐÀÇ »ó½ÂÀÌ ¿øÀÎÀÌ µÇ¸ç ȯÀÚ´Â ÁßÁõ ¾ËÄÚ¿Ã Áßµ¶°ú °ü·ÃµÈ ¸¸¼º ±¸ÅäÁõÀÌ ÀÖ´Ù. º´¸® ¼Ò°ßÀ¸·Î´Â À§Àå »óºÎ°¡ º¸Åë ħ¹üµÇ¸ç À§ ºÐ¹®ÀÇ ´ë¸¸ÀÌ °¡Àå ÈçÈ÷ ħ¹üµÈ´Ù. ÅëÁõÀº ¾øÀÌ À§Àå ÃâÇ÷ÀÌ »ý±ä´Ù. ÃâÇ÷ Áõ»óÀº Ç÷º¯º¸´Ù´Â ÅäÇ÷ÀÇ ÇüÅ·Πº¸Åë ³ªÅ¸³­´Ù. Áø´ÜÀº ³»½Ã°æÀ¸·Î Á¡¸· ¿­»óÀ» Áõ¸íÇÏ¿© È®ÁøÇϸç Ä¡·á´Â À§ Àå°ü ÃâÇ÷¿¡ ´ëÇÑ ´ëÁõÀû ¿ä¹ýÀ» ¸ÕÀú ½ÃÀÛÇÏ¿© ¸¸ÀÏ ÃâÇ÷ÀÌ Áö¼ÓµÇ¸é Áï½Ã ¼ö¼úÀ» ½ÃÇàÇÑ´Ù. ¼ö¼ú ÈÄ ¿¹ÈÄ´Â ÁÁ´Ù. 2. ½ÉÇÑ ±¸Åä¿Í ±¸¿ªÀÌ ¸î ½Ã°£ ¶Ç´Â ¸çÄ¥°£ Áö¼ÓµÈ ÈÄ¿¡ ÅäÇ÷, ÇÏÇ÷À» ÀÏÀ¸Å°´Â Áúȯ. 1929³â ¹Ì±¹ º´¸®ÇÐÀÚ G.K. ¸È·¯¸®¿Í ³»°úÀÇ»ç S. ¿ÍÀ̽º
  • Marcus Gunn's syndrome
    ¸¶Äí½º ±º ÁõÈıº
    À̼ø Çö»ó. ÇϾÇÀÇ ¿îµ¿°ú µ¿½Ã¿¡ »ó¾È°ËÀÌ ¿Ã¶ó°¡´Â Çö»ó.
  • medial superior pontine syndrome
    ³» »óÃø ±³»óºÎ ÁõÈıº
  • medulla syndrome
    ¿¬¼ö ÁõÈıº
  • megacystis-megaureter syndrome
    °Å´ë ¹æ±¤-°Å´ë ¿ä°ü ÁõÈıº
    ¹æ±¤ÀÇ È®Àå°ú ÀÌ¿ÏÀ» µ¿¹ÝÇÑ ¸¸¼ºÀû ¿ä°ü È®Àå°ú, ¿ä°ü ÀÔ±¸ÀÇ ºÐ¿­·Î ¿äÀÇ ¹æ±¤ ¿ª·ù¿Í ¸¸¼º ½Å¿ì¿°À» ÀÏÀ¸Å² °Í.
  • meigs syndrome
    ¸ÞÀ̱׽º ÁõÈıº
    ³­¼Ò ¼¶À¯Á¾ ¶Ç´Â °ñ¹Ý³» Á¾¾ç°ú µ¿¹ÝµÇ´Â º¹¼ö¿Í Èä¼ö.
  • Melkersson-Rosenthal syndrome
    ¸áÄ¿½¼ ·ÎÁ¨Å» ÁõÈıº
    À°¾ÆÁ¾¼º ±¸¼ø¿°ÀÌ ´Üµ¶À¸·Î ³ªÅ¸³ª°Å³ª ¼³ ±Õ¿­°ú ¾È¸é ½Å°æ ¸¶ºñ¿Í °ü·ÃµÇ¾î ³ªÅ¸³ª´Â °æ¿ì. ÀÌó·³ ÈçÇÏÁö ¾Ê´Â ¼¼ °¡Áö ¡Èĸ¦ ¸»ÇÑ´Ù.
  • Mendelson's syndrome
    ¸àµ¨½¼ ÁõÈıº
    »ïÃ⼺ ºÎÁ¾, ½ÉÇÑ ±â°üÁö¿°.
  • Meniere's syndrome
    ¸Þ´Ï¿¡¸£ ÁõÈıº
    ¹Ì·ÎÀÇ ºñÈ­³ó¼º º´ÀÎ ³»¸²ÇÁ¼º ¼öÁ¾¿¡¼­ ¿À´Â ³­Ã», À̸í, Çö±â.
  • meningitis syndrome
    ¼ö¸·¿° ÁõÈıº
  • Menkes kinky hair syndrome
    ¸àÄÉ Å²Å° ¸ð ÁõÈıº
    ¹Ý¼º ¿­¼º À¯Àüº´À¸·Î, µ¿ Èí¼öÀÇ ¼±ÃµÀû Àå¾Ö·Î »ý±ä´Ù. ½ÉÇÑ ´ë³ú º¯¼º, µ¿¸Æ º¯È­·Î ¿µ¾Æ±â¿¡ »ç¸ÁÇÑ´Ù.
  • metameric syndrome
    üÀý¼º ÁõÈıº
    ô¼öÀÇ È¸¹éÁúÀÇ Àå¾Ö¿¡ ÀÇÇÑ ÁõÈıºÀ¸·Î¼­, Àå¾ÖµÈ ºÐÀý Áö¹è ¿µ¿ªÀÇ ¼è¾à°ú ¼Ò¸ð¸¦ Ư¡À¸·Î ÇÑ´Ù.
  • middle cerebellar peduncle syndrome
    Áß ¼Ò³ú °¢ ÁõÈıº
  • midsystolic click syndrome
    ¼öÃà Áß±â Ŭ¸¯Å© ÁõÈıº
  • Mikulicz s syndrome
    ¹ÌÄð¸®Áî ÁõÈıº
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 19
paraneoplastic syndrome <oncology, syndrome> A collection of symptoms or clinical signs that are found in patients that have malignant disease. By definition, the signs and symptoms are not produced by a direct effect of a tumour or its metastasis nor due to direct invasion, compression, metastasis, infection, nutritional deficiency or treatment of the underlying neoplasm.
Paraneoplastic syndromes can arise from tumour produced biologically active polypeptides or proteins, autoimmunity or immune complex production and immune suppression, blockade of the normal effect of a hormone, the release of substances from tumour associated endothelium which are not normally released and finally unknown causes.
The best characterised paraneoplastic syndrome is the syndrome of inappropriate ADH.
(15 Dec 1997)
Marchiafava-Micheli syndrome An infrequent disorder with insidious onset (usually in the third or fourth decade) and chronic course, characterised by episodes of haemolytic anaemia, haemoglobinuria (chiefly at night), pallor, icterus or bronzing of the skin, a moderate degree of splenomegaly, and sometimes hepatomegaly; red blood cells are usually macrocytic and vary considerably in size, but there is no evidence of spherocytosis, erythrophagocytosis, or abnormal leukocytes. The disorder is a result of an abnormality of the red cell membrane which makes the red cell unusually sensitive to lysis by complement.
Synonym: Marchiafava-Micheli anaemia, Marchiafava-Micheli syndrome.
(05 Mar 2000)
Marcus Gunn syndrome <syndrome> An increase in the width of the eye lids during chewing, sometimes with a rhythmic elevation of the upper lid when the mouth is open and ptosis when the mouth is closed.
Synonym: Gunn phenomenon, Gunn's syndrome, jaw-winking phenomenon, jaw-working reflex, Marcus Gunn phenomenon, Marcus Gunn syndrome.
(05 Mar 2000)
Marfan's syndrome <syndrome> A hereditary condition of the connective tissue.
Symptoms and signs include tall lean body type, irregular or unsteady gait, long extremities (including fingers and toes), abnormal joint flexibility, flat feet, stooped shoulders, dislocation of the optic lens and aneurysms of the aorta. Affects 1 in 50,000 people. Probably a collagen fibril assembly disorder since it can be mimicked in mice by aminonitriles that interfere with crosslinking.
Inheritance: autosomal dominant.
(06 Oct 1997)
marfan syndrome <radiology> Connective-tissue disorder: autosomal dominant, 15% sporadic, cardiovascular system (probable cause of death in 93%), aortic aneurysm (mostly ascending), dilatation of aortic sinuses, aortic dissection, coarctation, musculoskeletal system, tall stature, long limbs, arachnodactyly, lax joints, scoliosis (60%) / kyphosis / pectus, eye, lens subluxation Cf: homocystinuria More info: Marfan syndrome
(12 Dec 1998)
Marie-Robinson syndrome <syndrome> Insomnia and mild melancholia associated with alimentary levulosuria.
(05 Mar 2000)
Marinesco-Garland syndrome <syndrome> A rare neurologic disorder characterised by cerebellolental degeneration with mental retardation; autosomal recessive inheritance.
Synonym: cataract-oligophrenia syndrome, Marinesco-Sjogren syndrome, Torsten Sjogren's syndrome.
(05 Mar 2000)
Marinesco-Sjogren syndrome <syndrome> A rare neurologic disorder characterised by cerebellolental degeneration with mental retardation; autosomal recessive inheritance.
Synonym: cataract-oligophrenia syndrome, Marinesco-Sjogren syndrome, Torsten Sjogren's syndrome.
(05 Mar 2000)
verner-morrison syndrome <radiology> WDHA syndrome, watery diarrhoea, hypokalaemia, achlorhydria, vasoactive intestinal peptide (VIP) secreted by, pancreatic isleT-cell tumour (VIPoma)
(12 Dec 1998)
Vernet's syndrome <syndrome> A syndrome characterised by paralysis of the motor components of the glossopharyngeal, vagus, and accessory cranial nerves as they lie in the posterior fossa; it is most commonly the result of head injury.
(05 Mar 2000)
Maroteaux-Lamy syndrome <biochemistry, syndrome> An error of mucopolysaccharide metabolism due to deficiency of the lysosomal enzyme arylsulphatase B.
It is characterised by excretion of dermatan sulfate in the urine, growth retardation, lumbar kyphosis, sternal protrusion, genu valgum, usually hepatosplenomegaly, and no mental retardation.
Onset occurs after two years of age.
Inheritance: autosomal recessive.
Synonym: polydystrophic dwarfism, mucopolysaccharidosis type VI.
(05 Mar 2000)
Marshall syndrome <syndrome> Syndrome of mid-face hypoplasia, cataract, sensorineural hearing loss, and hypohidrosis. It is disputed whether this syndrome is distinct from Stickler's syndrome.
(05 Mar 2000)
carotid artery occlusive syndrome <syndrome> Aortic arch syndrome, also referred to by many as vertebral-basilar artery disease, carotid artery occlusive syndrome and subclavian steal syndrome.
Characterised by a constellation of signs and symptoms which occur secondary to abnormalities in the major arteries which extend off of the aortic arch. These abnormalities are structural and most often secondary to the effects of atherosclerosis, blood clots, trauma or a congenital abnormality.
Symptoms of this condition include various neurologic symptoms, reduction in pulse and changes in blood pressure.
(27 Sep 1997)
carotid sinus syndrome <syndrome> Stimulation of a hyperactive carotid sinus, causing a marked fall in blood pressure due to vasodilation, cardiac slowing, or both; syncope with or without convulsions or A-V block may occur.
Synonym: Charcot-Weiss-Baker syndrome.
(05 Mar 2000)
Martorell's syndrome <syndrome> Aortic arch syndrome, also referred to by many as vertebral-basilar artery disease, carotid artery occlusive syndrome and subclavian steal syndrome is characterised by a constellation of signs and symptoms which occur secondary to abnormalities in the major arteries which extend off of the aortic arch. These abnormalities are structural and most often secondary to the effects of atherosclerosis, blood clots, trauma or a congenital abnormality. Symptoms of this condition include various neurologic symptoms, reduction in pulse and changes in blood pressure.
(27 Sep 1997)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 19
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 19
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 19
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 19
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 19
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 19
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 19
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 19
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 19
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 19
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 19
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 19
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 19
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 19
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 19
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 19
ÅëÇÕ°Ë»ö ¿Ï·á